Your browser doesn't support javascript.
loading
The use of glucose-lowering medications for the treatment of type 2 diabetes mellitus during pregnancy in the United States.
Wood, Mollie E; Patorno, Elisabetta; Huybrechts, Krista F; Bateman, Brian T; Gray, Kathryn J; Seely, Ellen W; Vine, Seanna; Hernández-Díaz, Sonia.
Afiliação
  • Wood ME; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
  • Patorno E; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Huybrechts KF; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Bateman BT; Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Gray KJ; Division of Maternal-Fetal Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Seely EW; Endocrinology, Diabetes and Hypertension Division, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Vine S; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Hernández-Díaz S; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
Endocrinol Diabetes Metab ; 5(2): e00319, 2022 03.
Article em En | MEDLINE | ID: mdl-34953068

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Metformina Tipo de estudo: Guideline Limite: Female / Humans / Male / Pregnancy País/Região como assunto: America do norte Idioma: En Revista: Endocrinol Diabetes Metab Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Metformina Tipo de estudo: Guideline Limite: Female / Humans / Male / Pregnancy País/Região como assunto: America do norte Idioma: En Revista: Endocrinol Diabetes Metab Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido